RAB0533
Human CLU / Clusterin ELISA Kit
for serum, plasma, cell culture supernatants and urine
別名:
Apo J, Apolipoprotein J, Clusterin
ログインで組織・契約価格をご覧ください。
サイズを選択してください
この商品について
NACRES:
NA.32
UNSPSC Code:
41116158
Gene information:
human ... CLU(1191)
Input:
sample type serum
sample type cell culture supernatant(s)
sample type plasma
sample type urine
sample type cell culture supernatant(s)
sample type plasma
sample type urine
Species reactivity:
human
Storage temp.:
−20°C
Shipped in:
wet ice
製品名
Human CLU / Clusterin ELISA Kit, for serum, plasma, cell culture supernatants and urine
species reactivity
human
packaging
kit of 96 wells (12 strips x 8 wells)
technique(s)
ELISA: suitable
input
sample type serum
sample type cell culture supernatant(s)
sample type plasma
sample type urine
assay range
inter-assay cv: <10%
intra-assay cv: <12%
sensitivity: 15 pg/mL
detection method
colorimetric
shipped in
wet ice
storage temp.
−20°C
Gene Information
human ... CLU(1191)
Application
For research use only. Not for use in diagnostic procedures.
Please refer to the attached General ELISA KIT Procedure (sandwich, competitive & Indirect ELISA)
Please refer to the attached General ELISA KIT Procedure (sandwich, competitive & Indirect ELISA)
General description
This ELISA antibody pair detect human Clusterin.
Other Notes
A sample Certificate of Analysis is available for this product.
Please type the word sample in the text box provided for lot number.
Please type the word sample in the text box provided for lot number.
signalword
Warning
hcodes
pcodes
Hazard Classifications
Met. Corr. 1
保管分類
8A - Combustible corrosive hazardous materials
flash_point_f
Not applicable
flash_point_c
Not applicable
Zhiyu He et al.
Journal of controlled release : official journal of the Controlled Release Society, 318, 86-97 (2019-12-16)
Liraglutide is a GLP-1 receptor agonist recently approved for Type-II diabetes (T2D) treatment with superior hypoglycemic effect while also improving cardiovascular function for the patients. However, its application has been limited by its short half-life (~13 h), which requires daily injections
Aman P Mann et al.
Nature communications, 8(1), 1403-1403 (2017-11-11)
Cerebrovascular changes occur in Alzheimer's disease (AD). Using in vivo phage display, we searched for molecular markers of the neurovascular unit, including endothelial cells and astrocytes, in mouse models of AD. We identified a cyclic peptide, CDAGRKQKC (DAG), that accumulates
Anna Bonaterra-Pastra et al.
Biomedicines, 9(1) (2021-01-16)
Cerebral amyloid angiopathy (CAA) refers to beta-amyloid (Aβ) deposition in brain vessels and is clinically the main cause of lobar intracerebral hemorrhage (ICH). Aβ can also accumulate in brain parenchyma forming neuritic plaques in Alzheimer's disease (AD). Our study aimed
Antara A Banerjee et al.
Biochemical and biophysical research communications, 531(4), 609-614 (2020-08-21)
The 5-HT2A receptor is a target for hallucinogenic and non-hallucinogenic ligands that evoke unique behavioral, electrophysiological and molecular consequences. Here, we explored the differential effects of distinct 5-HT2A receptor ligands on signaling pathways downstream to the 5-HT2A receptor. The hallucinogenic
Lili Donner et al.
Cellular signalling, 50, 121-130 (2018-07-03)
A pathological hallmark of Alzheimer's disease (AD) is the aggregation of amyloid-β peptides (Aβ) into fibrils, leading to deposits in cerebral parenchyma and vessels known as cerebral amyloid angiopathy (CAA). Platelets are major players of hemostasis but are also implicated
関連コンテンツ
Instructions
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）